KBL Merger Corp. IV

announcedU=S+1.50WW=S@11.50
ETHZSEC EDGARCIK: 0001690080|KBL IV Sponsor LLCPharmaceuticals

Capital Structure & Economics

Trust Size$101,000,000
Unit Price$1.41
Warrant Coverage1.50
Sponsor Promote20%

Implied Equity Architecture

Capital Allocation Baseline

Trust (100.0%)

Implied Dilution Drag

150% Warrant Inclusion
Public Trust Allocation$101,000,000
Sponsor At-Risk CapitalN/A
Total Underwriting DiscountN/A
Trust Per Unit (Implied)$1.41
Sponsor Promote Allocation20%
Deal Lifecycle
IPO PricedApr 26, 2017
SearchingTarget Pending
Maturation Wall
N/A

Announced Target / M&A

  • Target Company180 Life Sciences Corp.
  • SectorPharmaceuticals
  • Announced Deal Size$175,000,000

Board & Officers

Advanced Structuring Terms

Target SectorsPharmaceuticals

Interactive Deal Modeling

Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.